Edward T.H. Yeh
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Oncology top 0.2%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
Papers in
-
- Cancer, Hypoxia, and Metabolism 16
-
- Chemotherapy-induced cardiotoxicity and mitigation 30
- Co-authors
- James T. WillersonVincenzo PasceriTetsu KamitaniLimin GongCourtney L. BickfordJinke ChengSui ZhangPimprapa Vejpongsa
- Journals
- Journal of Biological Chemistry (32 papers)Circulation (16 papers)Circulation Research (6 papers)Oncogene (5 papers)Journal of the American College of Cardiology (5 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Edward T.H. Yeh
193 papers receiving 21.6k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Cardiology and Cardiovascular Medicine 5.6k
- Oncology 5.3k
- Molecular Biology 11.2k
- Cancer Research 2.2k
- Immunology 3.0k
Countries citing papers authored by Edward T.H. Yeh
This map shows the geographic impact of Edward T.H. Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward T.H. Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward T.H. Yeh more than expected).
Fields of papers citing papers by Edward T.H. Yeh
This network shows the impact of papers produced by Edward T.H. Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward T.H. Yeh. The network helps show where Edward T.H. Yeh may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward T.H. Yeh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | ANTHRACYCLINE-INDUCED CARDIOTOXICITY: MECHANISM AND PREVENTION. | 2025 | 1 |
| 2 | 2025 | 0 | |
| 3 | 2021 | 12 | |
| 4 | Immunological response and durability of expression following sequential intravitreal administration of AAV2.7m8 gene therapy to the contralateral eye in non-human primates | 2019 | 2 |
| 5 | 2017 | 262 | |
| 6 | 2013 | 83 | |
| 7 | 2013 | 31 | |
| 8 | 2012 | 37 | |
| 9 | 2011 | 21 | |
| 10 | Onco-cardiology: the time has come. | 2011 | 20 |
| 11 | Radiation-Related Heart Disease: Current Knowledge and Future Prospects Hit paper breakdown → | 2010 | 460 |
| 12 | 2010 | 11 | |
| 13 | PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin. | 2009 | 13 |
| 14 | 2006 | 177 | |
| 15 | 2006 | 122 | |
| 16 | 2001 | 108 | |
| 17 | 2001 | 87 | |
| 18 | 1999 | 73 | |
| 19 | 1999 | 75 | |
| 20 | Endotoxin-induced leukocyte accumulation in aqueous fluid of rats is decreased by a small molecule selectin antagonist | 1996 | 1 |
About Edward T.H. Yeh
Edward T.H. Yeh is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine, Oncology, Aging and Immunology, having authored 195 papers that have together received 22.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (58 papers), Chemotherapy-induced cardiotoxicity and mitigation (30 papers), Cancer Treatment and Pharmacology (21 papers), Adipokines, Inflammation, and Metabolic Diseases (17 papers), Mitochondrial Function and Pathology (16 papers), Cancer, Hypoxia, and Metabolism (16 papers), Peptidase Inhibition and Analysis (11 papers) and Lipoproteins and Cardiovascular Health (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (5.6k citations), Oncology (5.3k citations), Molecular Biology (11.2k citations), Cancer Research (2.2k citations) and Immunology (3.0k citations). Edward T.H. Yeh has collaborated with scholars based in United States, China and Canada. Frequent co-authors include James T. Willerson, Vincenzo Pasceri, Tetsu Kamitani, Limin Gong, Courtney L. Bickford, Jinke Cheng, Sui Zhang, Pimprapa Vejpongsa, Tasneem Bawa‐Khalfe and Paolo Calabrò. Their work appears in journals such as Journal of Biological Chemistry, Circulation, Circulation Research, Oncogene and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.